Repaglinide (1 mg) + Voglibose (0.3 mg) is a combination medication used to manage blood sugar levels in individuals with type 2 diabetes mellitus. It helps control high blood sugar, particularly after meals, by stimulating insulin release and slowing down carbohydrate absorption in the intestine.
